|
|
|
Volumn 30, Issue 4, 2006, Pages 58-66
|
|
Single-enantiomer drugs drive advances in asymmetric synthesis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHROMATOGRAPHIC ANALYSIS;
MIXTURES;
STEREOCHEMISTRY;
SUPERCRITICAL FLUIDS;
SYNTHESIS (CHEMICAL);
ASYMMETRIC SYNTHESIS;
BIOCATALYSIS;
RACEMIC MIXTURES;
DRUG PRODUCTS;
ADVAIR DISKUS;
ATORVASTATIN;
CLOPIDOGREL;
EPOXIDE HYDROLASE;
ESOMEPRAZOLE;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
LANSOPRAZOLE;
LIGAND;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PHOSPHINE DERIVATIVE;
RECOMBINANT ERYTHROPOIETIN;
SERTRALINE;
SIMVASTATIN;
ASYMMETRIC SYNTHESIS;
BIOCATALYST;
BIOTECHNOLOGY;
CATALYSIS;
CHIRALITY;
COST EFFECTIVENESS ANALYSIS;
DRUG RESEARCH;
ENANTIOMER;
ENANTIOSELECTIVITY;
ENZYME ACTIVITY;
HIGH THROUGHPUT SCREENING;
HUMAN;
LIQUID CHROMATOGRAPHY;
RACEMIC MIXTURE;
REVIEW;
STANDARD;
SUPERCRITICAL FLUID CHROMATOGRAPHY;
|
|
EID: 33748943300
PISSN: 15432521
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|